Intrathecal sufentanil and morphine for post-thoracotomy pain relief

Area of Science:

• Anesthesiology
• Pain Management
• Thoracic Surgery

Background:

• Post-thoracotomy pain management is crucial for patient recovery.
• Opioid-based analgesia is common but can have side effects.
• Optimizing pain relief while minimizing opioid consumption is a key goal.

Purpose of the Study:

• To compare the efficacy of intrathecal sufentanil and morphine versus standard care for post-thoracotomy pain.
• To evaluate intra-operative and post-operative opioid requirements.
• To assess the impact on respiratory function.

Main Methods:

• Double-blind, randomized study comparing intrathecal sufentanil/morphine with a control group.
• Pain assessment using visual analogue scale (VAS) and verbal rating scale.
• Intravenous (IV) morphine titration and patient-controlled analgesia (PCA) for 72 hours.
• Spirometry to measure respiratory function.

Main Results:

• The intrathecal sufentanil and morphine group showed reduced intra-operative opioid needs and less IV morphine for titration.
• Lower IV PCA morphine consumption and pain scores were observed in the active group during the first 24 hours post-surgery.
• No significant differences in spirometric data were found between the groups.

Conclusions:

• Combination of intrathecal sufentanil and morphine provides rapid-onset analgesia for thoracotomy patients.
• The analgesic effect lasts for approximately 24 hours.
• This approach effectively manages post-operative pain without compromising respiratory function.